OBJECTIVE: Up to 90% of adults with rheumatoid arthritis (RA) in clinical remission have persistent synovitis and/or bone marrow lesions (BMLs) on magnetic resonance imaging (MRI). MRI findings in patients with juvenile idiopathic arthritis (JIA) in clinical remission have not been described. We utilized 3T MRI with contrast enhancement to examine JIA patients with hand and/or wrist involvement who were in clinical remission and compared them with a cohort of adult RA patients. METHODS: In total, 11 JIA patients and 10 RA patients with arthritis involving the hands and/or wrists were identified by their primary rheumatologist as being in physician-defined clinical remission, having no signs or symptoms of active arthritis and no medication changes for at least 6 months. A study rheumatologist performed a joint evaluation for tenderness, swelling, and limitation of motion, and study participants self-reported tender joint counts. The participants underwent MRI with intravenous contrast enhancement of 1 hand and wrist with a history of prior symptoms. A pediatric musculoskeletal radiologist blinded to the clinical data scored the MRIs for synovitis, tenosynovitis, and/or BMLs. RESULTS: Sixty-three percent of the JIA cohort and 70% of the RA cohort had MRI findings of synovitis, BMLs, and/or tenosynovitis. All pediatric patients with MRI abnormalities had normal physician tender and swollen joint counts. The patients' self-report of painful joint counts did not predict MRI abnormalities. CONCLUSION: Over one-half of the patients in clinical remission had MRI evidence of persistent inflammation, defined as the presence of synovitis, tenosynovitis, or BMLs. A substantial portion of patients with JIA may have subclinical disease despite clinical remission.
OBJECTIVE: Up to 90% of adults with rheumatoid arthritis (RA) in clinical remission have persistent synovitis and/or bone marrow lesions (BMLs) on magnetic resonance imaging (MRI). MRI findings in patients with juvenile idiopathic arthritis (JIA) in clinical remission have not been described. We utilized 3T MRI with contrast enhancement to examine JIA patients with hand and/or wrist involvement who were in clinical remission and compared them with a cohort of adult RApatients. METHODS: In total, 11 JIA patients and 10 RApatients with arthritis involving the hands and/or wrists were identified by their primary rheumatologist as being in physician-defined clinical remission, having no signs or symptoms of active arthritis and no medication changes for at least 6 months. A study rheumatologist performed a joint evaluation for tenderness, swelling, and limitation of motion, and study participants self-reported tender joint counts. The participants underwent MRI with intravenous contrast enhancement of 1 hand and wrist with a history of prior symptoms. A pediatric musculoskeletal radiologist blinded to the clinical data scored the MRIs for synovitis, tenosynovitis, and/or BMLs. RESULTS: Sixty-three percent of the JIA cohort and 70% of the RA cohort had MRI findings of synovitis, BMLs, and/or tenosynovitis. All pediatric patients with MRI abnormalities had normal physician tender and swollen joint counts. The patients' self-report of painful joint counts did not predict MRI abnormalities. CONCLUSION: Over one-half of the patients in clinical remission had MRI evidence of persistent inflammation, defined as the presence of synovitis, tenosynovitis, or BMLs. A substantial portion of patients with JIA may have subclinical disease despite clinical remission.
Authors: Janet M Gardner-Medwin; Orla G Killeen; Clive A J Ryder; Karen Bradshaw; Karl Johnson Journal: J Rheumatol Date: 2006-09-15 Impact factor: 4.666
Authors: A K Brown; M A Quinn; Z Karim; P G Conaghan; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery Journal: Arthritis Rheum Date: 2006-12
Authors: Robert Hemke; Mario Maas; Mira van Veenendaal; Koert M Dolman; Marion A J van Rossum; J Merlijn van den Berg; Taco W Kuijpers Journal: Eur Radiol Date: 2013-10-08 Impact factor: 5.315
Authors: Robert Hemke; Taco W Kuijpers; Charlotte M Nusman; Dieneke Schonenberg-Meinema; Marion A J van Rossum; Koert M Dolman; J Merlijn van den Berg; Mario Maas Journal: Eur Radiol Date: 2015-05-23 Impact factor: 5.315
Authors: E Charlotte van Gulik; Mendy M Welsink-Karssies; J Merlijn van den Berg; Dieneke Schonenberg-Meinema; Koert M Dolman; Anouk M Barendregt; Charlotte M Nusman; Mario Maas; Taco W Kuijpers; Robert Hemke Journal: Pediatr Radiol Date: 2018-01-06
Authors: Sameen Yousaf; Patrick J S King; Aline F Miller; Alberto Saiani; David J Clarke; Linda T Trivoluzzi; Harmesh S Aojula; Elena V Bichenkova Journal: Anal Chem Date: 2019-07-11 Impact factor: 6.986
Authors: Varvara Choida; Margaret Hall-Craggs; Bethany R Jebson; Corinne Fisher; Maria Leandro; Lucy R Wedderburn; Coziana Ciurtin Journal: Front Pharmacol Date: 2021-02-02 Impact factor: 5.810
Authors: Robert Hemke; J Merlijn van den Berg; Charlotte M Nusman; E Charlotte van Gulik; Anouk M Barendregt; Dieneke Schonenberg-Meinema; Koert M Dolman; Taco W Kuijpers; Mario Maas Journal: Eur Radiol Date: 2017-10-06 Impact factor: 5.315